These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2957611)

  • 1. The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease.
    Hayden MR; Hewitt J; Stoessl AJ; Clark C; Ammann W; Martin WR
    Neurology; 1987 Sep; 37(9):1441-7. PubMed ID: 2957611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal caudate glucose metabolism in persons at risk for Huntington's disease.
    Young AB; Penney JB; Starosta-Rubinstein S; Markel D; Berent S; Rothley J; Betley A; Hichwa R
    Arch Neurol; 1987 Mar; 44(3):254-7. PubMed ID: 2950844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease.
    Kuhl DE; Markham CH; Metter EJ; Riege WH; Phelps ME; Mazziotta JC
    Res Publ Assoc Res Nerv Ment Dis; 1985; 63():199-209. PubMed ID: 3161165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease.
    Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME
    Arch Neurol; 1992 Nov; 49(11):1161-7. PubMed ID: 1444883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease.
    Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME
    Ann Neurol; 1990 Nov; 28(5):614-21. PubMed ID: 1979723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral metabolism of glucose in benign hereditary chorea.
    Suchowersky O; Hayden MR; Martin WR; Stoessl AJ; Hildebrand AM; Pate BD
    Mov Disord; 1986; 1(1):33-44. PubMed ID: 2973557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric, genetic, and positron emission tomographic evaluation of persons at risk for Huntington's disease.
    Baxter LR; Mazziotta JC; Pahl JJ; Grafton ST; St George-Hyslop P; Haines JL; Gusella JF; Szuba MP; Selin CE; Guze BH
    Arch Gen Psychiatry; 1992 Feb; 49(2):148-54. PubMed ID: 1532304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease.
    Kuhl DE; Metter EJ; Riege WH; Markham CH
    Ann Neurol; 1984; 15 Suppl():S119-25. PubMed ID: 6234856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography in the early diagnosis of Huntington's disease.
    Hayden MR; Martin WR; Stoessl AJ; Clark C; Hollenberg S; Adam MJ; Ammann W; Harrop R; Rogers J; Ruth T
    Neurology; 1986 Jul; 36(7):888-94. PubMed ID: 2940474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study.
    Feigin A; Leenders KL; Moeller JR; Missimer J; Kuenig G; Spetsieris P; Antonini A; Eidelberg D
    J Nucl Med; 2001 Nov; 42(11):1591-5. PubMed ID: 11696626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease.
    Mazziotta JC; Phelps ME; Pahl JJ; Huang SC; Baxter LR; Riege WH; Hoffman JM; Kuhl DE; Lanto AB; Wapenski JA
    N Engl J Med; 1987 Feb; 316(7):357-62. PubMed ID: 2949152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.
    Antonini A; Leenders KL; Spiegel R; Meier D; Vontobel P; Weigell-Weber M; Sanchez-Pernaute R; de Yébenez JG; Boesiger P; Weindl A; Maguire RP
    Brain; 1996 Dec; 119 ( Pt 6)():2085-95. PubMed ID: 9010012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presymptomatic testing for Huntington's disease. A case complicated by recombination within the D4S10 locus.
    Curtis A; Millan F; Holloway S; Mennie M; Crosbie A; Raeburn JA; Brock DJ
    Hum Genet; 1989 Jan; 81(2):188-90. PubMed ID: 2563253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain glucose utilization in childhood Huntington's disease studied with positron emission tomography (PET).
    De Volder A; Bol A; Michel C; Cogneau M; Evrard P; Lyon G; Goffinet AM
    Brain Dev; 1988; 10(1):47-50. PubMed ID: 2967038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional caudate imaging in symptomatic Huntington's disease: positron emission tomography versus single-photon emission computed tomography.
    Martin WR; Hoskinson M; Kremer B; Maguire C; McEwan A
    J Neuroimaging; 1995 Oct; 5(4):227-32. PubMed ID: 7579751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of caudate nucleus area--a more accurate measurement for Huntington's disease?
    Wardlaw JM; Sellar RJ; Abernethy LJ
    Neuroradiology; 1991; 33(4):316-9. PubMed ID: 1833664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies in persons at risk for Huntington's disease.
    N Engl J Med; 1987 Aug; 317(6):382-4. PubMed ID: 2955223
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan.
    Kuhl DE; Phelps ME; Markham CH; Metter EJ; Riege WH; Winter J
    Ann Neurol; 1982 Nov; 12(5):425-34. PubMed ID: 6217782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive testing for Huntington's disease with use of a linked DNA marker.
    Meissen GJ; Myers RH; Mastromauro CA; Koroshetz WJ; Klinger KW; Farrer LA; Watkins PA; Gusella JF; Bird ED; Martin JB
    N Engl J Med; 1988 Mar; 318(9):535-42. PubMed ID: 2893260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline.
    Young AB; Penney JB; Starosta-Rubinstein S; Markel DS; Berent S; Giordani B; Ehrenkaufer R; Jewett D; Hichwa R
    Ann Neurol; 1986 Sep; 20(3):296-303. PubMed ID: 2945510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.